MSF_Auto Rikshaw_Mumbai_India
We fill gaps in India’s health system and provide specific medical care to neglected people who would otherwise struggle to access it.

We have a number of long-standing projects in India, which we run in conjunction with the state authorities to address specific healthcare needs and emerging public health concerns.

We also run mobile clinics in remote areas of the country, where even preventable, treatable conditions such as malaria can assume life-threatening proportions.

Key Activities

Our Activities in India in 2022

Data and information from the International Activity Report 2022. 

MSF in India in 2022 In India, Doctors Without Borders continued to provide treatment for patients living with drug-resistant tuberculosis (DR-TB) and HIV and medical and psychological care for people affected by conflict and violence.

In the capital, New Delhi, we run a clinic for victims of sexual and gender-based violence, offering round-the-clock care. In December, we organised a national-level symposium calling for better access to medical and psychological care for victims.

Throughout the year, we provided mental health and psychosocial support to people affected by the conflict in Kashmir and ran mobile clinics offering basic healthcare to communities in remote areas of Chhattisgarh.

In Mumbai, MSF’s clinic focuses on treating complex cases of DR-TB, including extensively drug-resistant forms of the disease, with innovative drug combinations. For children under five, we implement all-oral regimens, thereby avoiding the need for painful injections.

In addition, we are working with the National Tuberculosis Elimination Programme and Municipal Corporation of Greater Mumbai to reduce the high TB incidence and death rates in the area. Our team co-manages a DR-TB centre in a public hospital, and we support diagnosis, treatment, counselling, health promotion and follow-up in general healthcare facilities.

In 2022, we also continued treating patients enrolled in the endTB clinical trial with the aim of generating more evidence for shorter, more tolerable, injection-free treatments for multidrug-resistant TB.

Our project in Manipur implements a person-centred care approach for people living with HIV, TB, DR-TB and hepatitis C. We transferred many of our stable HIV patients to Ministry of Health facilities, enabling us to focus on those with co-infections and complications. We also run a one-stop care centre offering comprehensive services for intravenous drug users.

In one of India’s poorest states, Bihar, we provide both lifesaving and palliative care to patients living with advanced HIV.

Our toll-free telemedicine helpline supports diabetes patients in managing their condition. India has the second-highest burden of diabetes globally, and the prevention and management of the disease, as well as its associated complications, remain a huge challenge.

MSF, Doctors without borders, India, Kala Azar

Kala Azar Explainer

Have you heard of kala azar?

KALA AZAR IS A NEGLECTED BUT POTENTIALLY FATAL TROPICAL DISEASE. INDIA ACCOUNTS FOR 30 PER CENT OF CASES WORLDWIDE. This short animation explains what kala azar is, how it relates to HIV, and what we are doing in response.

Since 80 per cent of India's kala azar cases are reported in Bihar, we set up a programme there in 2007.

People living with HIV are particularly vulnerable to kala azar, so since 2016 we have been focusing on treating patients co-infected with the two diseases, in partnership with the Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Bihar.

MSF, Doctors Without Borders, India rejects Johnson & Johnson patent extension attempt
Drug-resistant TB

MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug

Press Release 23 Mar 2023
MSF, Doctors without Borders, Daily dosage of pills
Multi-drug Resistant Tuberculosis

Major opportunity to increase access to newer, safer DR-TB drugs is at risk

Press Release 7 Nov 2022
COVID-19 wards and COVID-19 suspect wards are also acute internal medicine wards, where there are a range of comorbidities to be managed
Coronavirus COVID-19 pandemic

MSF responds to potential compromise on the ‘TRIPS Waiver’

Press Release 17 Mar 2022
Advanced HIV patient lying on a cloth on the ground

ViiV will not license new game-changing long-acting HIV prevention drug to generic manufacturers

Press Release 4 Mar 2022
MSF's COVID-19 response
Coronavirus COVID-19 pandemic

Letter: Launch of negotiations on TRIPS IP waiver at the WTO

Open Letter 29 May 2021
An Auto-Rikshaw (tuktuk) visiting alley lanes of Mumbai’s M-East Ward slums to generate COVID-19 Awareness
Coronavirus COVID-19 pandemic

“No one was ready for the second wave. It caught everybody by surprise"

Patient and Staff Stories 13 May 2021